loading

Finanzdaten der Turnstone Biologics Corp-Aktie (TSBX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-03-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - 19.31
Operating Expenses
15.88%
20.69
17.86 18.93 19.70
Operating Income/Loss
15.88%
-20.69
-17.86 -18.93 -0.394
Nonoperating Income/Loss
13.13%
1.078
1.241 1.578 0.38
Income/Loss From Continuing Operations Before Tax
18.04%
-19.61
-16.61 -17.35 0.068
Income Tax Expense/Benefit
109.70%
0.016
-0.165 -0.033 -0.082
Income/Loss From Continuing Operations After Tax
19.33%
-19.63
-16.45 -17.32 0.068
Net Income/Loss
19.33%
-19.63
-16.45 -17.32 0.068
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
500.48%
23.01
3.8322 17.40 -12.51
Diluted Average Shares
500.48%
23.01
3.8322 17.40 -12.51
Basic Earnings Per Share
454.17%
-0.85
0.24 -1.00 3.54
Diluted Earnings Per Share
454.17%
-0.85
0.24 -1.00 3.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):